Silver Spike Investment Corp. (NASDAQ:SSIC), a specialty finance company that has elected to be regulated as a business development company, announced its financial results Friday for the first quarter ended March 31, 2024. "It was recently reported that the U.S. Drug Enforcement Administration is moving to reclassify cannabis to a Schedule III substance under the Controlled Substances Act, a potentially historic shift in federal regulation of the cannabis industry," stated Scott Gordon, chairman and CEO of the company. "Although timing is uncertain, this shift would be a major step forward for the cannabis industry and should have a positive impact on cash flow for cannabis operators, as they would no longer be subject to Section ...